Topical Therapy is First Line Treatment for Chronic Anal Fissure because of the Risk of Incontinence with Sphincterotomy

2008 ◽  
Vol 51 (7) ◽  
pp. 1157-1158 ◽  
Author(s):  
David Lubowski
2011 ◽  
Vol 18 (04) ◽  
pp. 562-565
Author(s):  
ABID HUSSAIN ◽  
KISHWAR NAHEED

Objective: To determine the role of chemical syphincterotomy as non surgical management of chronic anal fissure. Study Design: Descriptive. Setting: This study was conducted at Margalla teaching Hospital and United Medical center .Rawalpndi. Period: 1½ years. Patients & Methods: This study included 70 patients of either sex. A personal bio data and detailed history of dietary and bowel habits were registered. Topical 0.2% GTN (Gylciryltrinitrate) was applied to anal verge 2 times per day for the period of two months and its effects were noted. Result: 58 patients (83%) got symptomatic relief and 12 patients (17%) did not get improvement. Conclusions: Chemical syphincterotomy heals majority of the fissure . Topical 0.2% GNT ointment is widely used as a first line treatment in U.K . It is generally accepted as an effective treatment for chronic fissure .


2014 ◽  
Vol 114 (4) ◽  
pp. 261-265 ◽  
Author(s):  
M. Dessily ◽  
F. Charara ◽  
E. Chelala ◽  
A.-L. Donfut ◽  
J.-L. Alle

Gut ◽  
1999 ◽  
Vol 44 (5) ◽  
pp. 727-730 ◽  
Author(s):  
E A Carapeti ◽  
M A Kamm ◽  
P J McDonald ◽  
S J D Chadwick ◽  
D Melville ◽  
...  

BACKGROUNDTopical application of glyceryl trinitrate (GTN) ointment heals chronic anal fissures, providing an alternative to the traditional first line treatment of surgical sphincterotomy.AIMSTo determine the most effective dose of topical GTN for treatment of chronic anal fissures and to assess long term results.METHODSSeventy consecutive patients with chronic anal fissure, were randomly allocated to eight weeks treatment with placebo, 0.2% GTN three times daily, or GTN starting at 0.2% with weekly 0.1% increments to a maximum of 0.6%, in a double blind study.RESULTSAfter eight weeks fissure had healed in 67% of patients treated with GTN compared with 32% with placebo (p=0.008). No significant difference was seen between the two active treatments. Headaches were reported by 72% of patients on GTN compared with 27% on placebo (p<0.001). Maximum anal sphincter pressure reduced significantly from baseline by GTN treatment (p=0.02), but not placebo (p=0.8). Mean pain scores were lower after treatment with GTN compared with placebo (NS). Of fissures healed with placebo 43% recurred, compared with 33% of those healed with 0.2% GTN and 25% healed with escalating dose GTN (p=0.7).CONCLUSIONSGTN is a good first line treatment for two thirds of patients with anal fissure. An escalating dose of GTN does not result in earlier healing. Significant recurrence of symptomatic fissures and a high incidence of headaches are limitations of the treatment.


Sign in / Sign up

Export Citation Format

Share Document